Hemiplegic migraine type 2 with new mutation of the ATP1A2 gene in Japanese cases

We analyzed the clinical symptoms of hemiplegic migraine (HM) and their relevance in four Japanese patients considered to have ATP1A2 mutations as a cause. Sequencing of ATP1A2 was performed using the Sanger method in 43 blood samples from clinically suspected patients with familial HM. Subsequently, algorithm analysis, allele frequency determination, and three-dimensional structure analysis of the recognized variants were performed, and the recognized variants were evaluated. We found four heterozygous missense mutations in ATP1A2 (Case 1: p.R51C; Case 2: p.R65L; Case 3: p.A269P; Case 4: p.D999H), three of which had not been reported to date. These four mutations may also affect the structure of the protein products, as assessed using a three-dimensional structural analysis. In all four cases, the clinical symptoms included visual, sensory, motor, and verbal symptoms and the frequency and duration of headache attacks varied. Additionally, oral administration of a combination of lomerizine hydrochloride and topiramate had a partial effect in three cases. We report four missense mutations in ATP1A2. This report will be useful for the future analysis of mutations and clinical types in Asians, as well as Westerners, with migraine.

Automated summary

This study analyzed the clinical symptoms of hemiplegic migraine (HM) and their relevance in four Japanese patients with ATP1A2 mutations. Four heterozygous missense mutations in ATP1A2 were found in these patients, three of which were previously unreported. These mutations may affect the structure of the protein products. The clinical symptoms of the patients included visual, sensory, motor, and verbal symptoms, with varying frequency and duration of headache attacks.